Annual Cash & Cash Equivalents
$182.48 M
+$140.90 M+338.92%
December 31, 2024
Summary
- As of March 3, 2025, PRME annual cash & cash equivalents is $182.48 million, with the most recent change of +$140.90 million (+338.92%) on December 31, 2024.
- During the last 3 years, PRME annual cash & cash equivalents has fallen by -$2.94 million (-1.59%).
- PRME annual cash & cash equivalents is now -2.74% below its all-time high of $187.62 million, reached on December 31, 2022.
Performance
PRME Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$182.48 M
+$64.50 M+54.67%
December 31, 2024
Summary
- As of March 3, 2025, PRME quarterly cash and cash equivalents is $182.48 million, with the most recent change of +$64.50 million (+54.67%) on December 31, 2024.
- Over the past year, PRME quarterly cash and cash equivalents has increased by +$88.31 million (+93.79%).
- PRME quarterly cash and cash equivalents is now -1.59% below its all-time high of $185.42 million, reached on December 31, 2021.
Performance
PRME Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PRME Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +338.9% | +93.8% |
| 3 y3 years | -1.6% | +93.8% |
| 5 y5 years | +393.5% | +93.8% |
PRME Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.7% | +338.9% | -1.6% | +338.9% |
| 5 y | 5-year | -2.7% | +393.5% | -1.6% | +338.9% |
| alltime | all time | -2.7% | +393.5% | -1.6% | +338.9% |
Prime Medicine Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $182.48 M(+338.9%) | $182.48 M(+54.7%) |
| Sep 2024 | - | $117.98 M(+112.2%) |
| Jun 2024 | - | $55.60 M(-41.0%) |
| Mar 2024 | - | $94.16 M(+126.5%) |
| Dec 2023 | $41.57 M(-77.8%) | $41.57 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $187.62 M(+1.2%) | - |
| Sep 2022 | - | $47.95 M(-48.0%) |
| Jun 2022 | - | $92.24 M(-50.3%) |
| Dec 2021 | $185.42 M(+401.5%) | $185.42 M |
| Dec 2020 | $36.98 M | - |
FAQ
- What is Prime Medicine annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Prime Medicine?
- What is Prime Medicine annual cash & cash equivalents year-on-year change?
- What is Prime Medicine quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Prime Medicine?
- What is Prime Medicine quarterly cash and cash equivalents year-on-year change?
What is Prime Medicine annual cash & cash equivalents?
The current annual cash & cash equivalents of PRME is $182.48 M
What is the all time high annual cash & cash equivalents for Prime Medicine?
Prime Medicine all-time high annual cash & cash equivalents is $187.62 M
What is Prime Medicine annual cash & cash equivalents year-on-year change?
Over the past year, PRME annual cash & cash equivalents has changed by +$140.90 M (+338.92%)
What is Prime Medicine quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PRME is $182.48 M
What is the all time high quarterly cash and cash equivalents for Prime Medicine?
Prime Medicine all-time high quarterly cash and cash equivalents is $185.42 M
What is Prime Medicine quarterly cash and cash equivalents year-on-year change?
Over the past year, PRME quarterly cash and cash equivalents has changed by +$88.31 M (+93.79%)